国药现代：新聘总裁及董事将助力公司高质量发展

证券之星08-06

证券之星消息，国药现代(600420)08月06日在投资者关系平台上答复投资者关心的问题。

投资者提问：近两三年，贵公司换了两三界总裁和董事长，然后我个人翻了下贵司高层的履历，基本上都是快退休的老人来当一把手，请问，作为最高级别的医药央企，频繁高层更换，是否国药体系太大，有临近退休镀金一下的说法？新任老总马上就上任了，请问该任老总是现代平稳退休的，还是带领国药总创辉煌来的？

国药现代回复：尊敬的投资者：您好！公司新近聘任的总裁及提名董事均拥有深厚的行业经验和良好的教育背景，这也将助力公司持续推进中长期战略发展规划，积极采取各项措施推动公司高质量发展。感谢您的关注！

本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。

责任编辑：刘浩然

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/2657468546?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-08-06 16:15","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2657468546","market":"fut","top_or_hot":-1,"title":"国药现代：新聘总裁及董事将助力公司高质量发展","media":"证券之星","content":"<html><body><p>证券之星消息，<a href=\"https://laohu8.com/S/600420\">国药现代</a>(600420)08月06日在投资者关系平台上答复投资者关心的问题。</p><p>投资者提问：近两三年，贵公司换了两三界总裁和董事长，然后我个人翻了下贵司高层的履历，基本上都是快退休的老人来当一把手，请问，作为最高级别的医药央企，频繁高层更换，是否<a href=\"https://laohu8.com/S/600511\">国药</a>体系太大，有临近退休镀金一下的说法？新任老总马上就上任了，请问该任老总是现代平稳退休的，还是带领<a href=\"https://laohu8.com/S/08156\">国药</a>总创<a href=\"https://laohu8.com/S/002296\">辉煌</a>来的？</p><p>国药现代回复：尊敬的投资者：您好！公司新近聘任的总裁及提名董事均拥有深厚的行业经验和良好的教育背景，这也将助力公司持续推进中长期战略发展规划，积极采取各项措施推动公司高质量发展。感谢您的关注！</p><p>本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。</p><p>责任编辑：刘浩然</p></body></html>","source":"stockstar","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>国药现代：新聘总裁及董事将助力公司高质量发展</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n国药现代：新聘总裁及董事将助力公司高质量发展\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-08-06 16:15 北京时间&nbsp;&nbsp;&nbsp;<a href=https://stock.stockstar.com/RB2026080600025387.shtml><strong>证券之星</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>证券之星消息，国药现代(600420)08月06日在投资者关系平台上答复投资者关心的问题。投资者提问：近两三年，贵公司换了两三界总裁和董事长，然后我个人翻了下贵司高层的履历，基本上都是快退休的老人来当一把手，请问，作为最高级别的医药央企，频繁高层更换，是否国药体系太大，有临近退休镀金一下的说法？新任老总马上就上任了，请问该任老总是现代平稳退休的，还是带领国药总创辉煌来的？国药现代回复：尊敬的投资者...</p>\n\n<a href=\"https://stock.stockstar.com/RB2026080600025387.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0082","symbol_name":"国资改革","start_time":0,"source_url":"https://stock.stockstar.com/RB2026080600025387.shtml","article_id":"2657468546","we_media_id":"1082532455","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2657468546","pubTimestamp":1786004110,"columns":[],"sourceInfo":{"source_id":"stockstar","name":"证券之星"},"weMediaInfo":{"media_name":"证券之星","introduction":"证券之星始创于1996年，是国内领先的金融信息及综合服务平台。关注证券之星，即时获取有价值的财经资讯。","home_visible":1,"id":"1082532455","head_image":"https://community-static.tradeup.com/news/2e305640fc27210243042d09d3a7fa3f"},"summary":"证券之星消息，国药现代08月06日在投资者关系平台上答复投资者关心的问题。公司新近聘任的总裁及提名董事均拥有深厚的行业经验和良好的教育背景，这也将助力公司持续推进中长期战略发展规划，积极采取各项措施推动公司高质量发展。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600420":"国药现代","BK0082":"国资改革","BK0010":"央企","BK0239":"医药制造","BK0020":"浦东新区","BK0132":"高送转概念"},"translate_title":"Sinopharm Hyundai: Newly appointed president and directors will help the high-quality development of the company","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600420":1.5},"content_text":"证券之星消息，国药现代(600420)08月06日在投资者关系平台上答复投资者关心的问题。投资者提问：近两三年，贵公司换了两三界总裁和董事长，然后我个人翻了下贵司高层的履历，基本上都是快退休的老人来当一把手，请问，作为最高级别的医药央企，频繁高层更换，是否国药体系太大，有临近退休镀金一下的说法？新任老总马上就上任了，请问该任老总是现代平稳退休的，还是带领国药总创辉煌来的？国药现代回复：尊敬的投资者：您好！公司新近聘任的总裁及提名董事均拥有深厚的行业经验和良好的教育背景，这也将助力公司持续推进中长期战略发展规划，积极采取各项措施推动公司高质量发展。感谢您的关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：刘浩然","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"executive","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2657468546","isCrawlerRequest":true}